NDMA was one of several nitrosamine impurities implicated in the massive recall of angiotensin II receptor blockers (ARBs) since last year.
Nine or more MET hours per week tied to lower risk for grade ≥3 treatment-related adverse events.
Survey results show level of concordance between patients with CRC and their caregivers when rating care quality. The survey also measured whether clinical or demographic factors influenced the agreement between patient-caregiver pairs.
According to this prospective study, the lifetime risk of cancer in men with a pathogenic germline MSH6 alteration is relatively low.
Lipophilic statins were linked to a lower risk of hepatocellular carcinoma and death in a cohort of patients with chronic hepatitis B/C.
Findings seen for patients receiving direct-acting antivirals with complete response to liver cancer treatment.
Study suggests aspirin is hepatoprotective, improves survival by reducing liver inflammation.
The new findings may extend the availability of MSI detection to all patients regardless of it they have tissue available for testing.
Young colorectal cancer patients more often present via emergency; have lowest percentage early-stage cancer.
Compared with patients who had gastric gastrointestinal stromal tumors (GISTs), patients with small intestinal GISTs had worse survival and clinical features.
The Breakthrough Therapy designation was based on updated interim results from the multicenter, open-label, phase 1b KEYNOTE-524/Study 116 trial.
Targeted screening should be considered in high-risk patients following H. pylori eradication therapy.
Younger adults presenting with colorectal cancer present with more advanced disease than older adults.
Authors call for new screening strategies for anal cancer prevention in women living with HIV.
Mvasi (bevacizumab-awwb), a biosimilar to Avastin (bevacizumab), and Kanjinti (trastuzumab-anns), a biosimilar to Herceptin (trastuzumab) have been made available by Amgen and Allergan.
A case report suggests that endoscopic techniques may have utility in the diagnosis of the gastric involvement that can occur in follicular lymphoma.
Early results from the Polish II study showed a significant improvement in OS for preoperative short-course RT/chemotherapy compared with long-term chemo-RT.
Age was not a significant prognostic factor for long-term survival after transthoracic esophagectomy among patients with thoracic esophageal cancer.
In site-specific analyses, significant correlation seen for poor oral health with hepatocellular carcinoma.
Kanjinti, a HER2/neu receptor antagonist, is indicated for adjuvant treatment of HER2-overexpressing node positive or node negative.